Clinical trials in Coburg – page 2

22 clinical trials in Coburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in GermanyKlinischeStudien.de

Coburg at a glance

clinical trials

Paediatric trials0
Research sites0

Quick filters

22 trials in Coburg

Open in trial search

Chronic kidney disease

Not recruiting

Study of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease

Registered drug

Study of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:BI 690517
Sponsor:Boehringer Ingelheim International GmbH

Contact Research Centre

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Ziltivekimab
Sponsor:Novo Nordisk A/S

Contact Research Centre

Rectal cancer

Not recruiting

Study Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients

Registered drugNo placebo

Study Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Goethe University Frankfurt

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Study on Long-Term Anticoagulation with Rivaroxaban vs. Acetylsalicylic Acid for Patients at Risk of Stroke After Atrial Fibrillation Ablation

Registered drugNo placebo

Study on Long-Term Anticoagulation with Rivaroxaban vs. Acetylsalicylic Acid for Patients at Risk of Stroke After Atrial Fibrillation Ablation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:University Of Ottawa Heart Institute

Contact Research Centre

Cardiac failure

Not recruiting

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug

Study of XXB750 and Drug Combination for Patients with Heart Failure

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Azilsartan Medoxomil
Sponsor:Novartis Pharma AG

Contact Research Centre

Colon cancer stage II+1

Not recruiting

Study on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal

Registered drugNo placebo

Study on Adjuvant Therapy with Capecitabine for Stage II Colon and Rectal Cancer Patients with Positive ctDNA After Tumor Removal

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Technische Universitat Dresden

Contact Research Centre

Hypertension

Not recruiting

Study on the Effectiveness of Ethanol in Treating Hypertension in Patients with Uncontrolled High Blood Pressure

InvestigationalNo placebo

Study on the Effectiveness of Ethanol in Treating Hypertension in Patients with Uncontrolled High Blood Pressure

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ethanol, Anhydrous
Sponsor:Ablative Solutions Inc.

Contact Research Centre

Hypercholesterolaemia

Not recruiting

Study on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels

Registered drug

Study on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Inclisiran
Sponsor:Novartis Pharma AG

Contact Research Centre

Heart failure with reduced ejection fraction

Not recruiting

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational

Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Vericiguat
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Acute coronary syndrome

Not recruiting

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Janssen Cilag International

Contact Research Centre

Other cities in Germany

The busiest research cities in the country

All 518 cities in Germany

Clinical research in Coburg

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on hypercholesterolemia and hypertension management, exploring new therapeutic approaches for blood pressure control and cholesterol reduction.

Lipid Management Studies
Blood Pressure Control Research
Heart Failure Treatments

Advanced trials investigating renal denervation techniques and combination therapies for cardiovascular conditions.

02 Oncology Studies

Comprehensive research targeting colorectal cancer treatments, including innovative approaches for both colon and rectal cancer management.

Stage II-III Colorectal Cancer
Adjuvant Therapy Studies
Organ Preservation Protocols

Exploring personalized treatment strategies and novel therapeutic combinations for better patient outcomes.

03 Cardiac Rhythm Management

Studies examining treatments for atrial fibrillation and related conditions, with emphasis on preventing stroke and other cardiovascular complications.

Anticoagulation Therapies
Post-Ablation Care
Stroke Prevention

Evaluating advanced therapeutic options for patients with complex cardiac conditions requiring specialized care.

Back to Germany All countries